News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medigus (MDGS.TA) Announces Three-Year Follow Up Study Presented At Digestive Disease Week 2014 Showing Treatment With MUSE™ System Keeps Patients Off Daily PPI Therapy


5/7/2014 9:19:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OMER, Israel, May 7, 2014 (GLOBE NEWSWIRE) -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally-invasive, endosurgical tools and procedures, announced today that two presentations involving the use of its MUSE(TM) System (formerly the SRS(TM) System) were presented at the prominent Digestive DiseaseĀ® Week (DDW) annual meeting, the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery, which took place this week in Chicago IL.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Medigus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES